| 6-OHDA | 6-hydroxydopamine |
| AD | Alzheimer’s disease |
| α-syn | α-synuclein |
| BBB | blood–brain barrier |
| BDNF | brain-derived neurotrophic factor |
| C3 | complement component 3 |
| CDNF | conserved dopamine neurotrophic factor |
| CJD | Creutzfeldt–Jakob disease |
| CNS | central nervous system |
| DA | dopamine |
| ER-phagy | endoplasmic reticulum autophagy |
| FAM134B | family with sequence similarity 134, member B |
| fNSC | fetal neural stem cell |
| fVM | fetal ventral mesencephalic |
| GBA | glucocerebrosidase |
| GDNF | glial cell line-derived neurotrophic factor |
| GLP1R | glucagon-like peptide-1 receptor |
| GMP | Good Manufacturing Practice |
| hESC | human embryonic stem cell |
| HGF | hepatocyte growth factor |
| hiPSC-DPs | human induced pluripotent stem cell-derived dopaminergic progenitors |
| HLA | human leukocyte antigen |
| hPSC | human pluripotent stem cell |
| hVM | human ventral mesencephalic |
| iNs | iPS-derived neurons |
| iPSC | induced pluripotent stem cell |
| LBs | Lewy bodies |
| LRRK2 | leucine-rich repeat kinase 2 |
| mDA | mesencephalic dopaminergic |
| MDS-UPDRS | Movement Disorder Society-sponsored revision of the Unified Parkinson‘s Disease Rating Scale |
| MPP | 1-methyl-4-phenylpyridinium |
| MPTP | 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine |
| MSC | mesenchymal stem cell |
| mtDNA | mitochondrial DNA |
| NMSS | Non-Motor Symptoms Scale |
| Nrf2-Keap1 | nuclear factor erythroid 2-related factor 2-Kelch-like ECH-associated protein 1 |
| nTD | non-tremor-dominant |
| NTN | neurturin |
| OFF | off-medication state |
| ON | on-medication state |
| PD | Parkinson’s disease |
| PDQ-39 | Parkinson’s Disease Questionnaire-39 |
| PET | positron emission tomography |
| PFFs | preformed fibrils |
| PI3K/AKT/GSK3β | phosphoinositide 3-kinase/protein kinase B/glycogen synthase kinase 3 beta |
| PIGD | postural instability and gait difficulty |
| PINK1 | PTEN-induced kinase 1 |
| POLG | DNA polymerase gamma |
| PRKN | parkin RBR E3 ubiquitin protein ligase |
| PSPN | persephin |
| ROS | reactive oxygen species |
| siRNA | mall interfering RNA |
| shRNA | short hairpin RNA |
| SN | substantia nigra |
| SNc | substantia nigra pars compacta |
| SNCA | synaptic nucleoprotein-alpha |
| SVF | stromal vascular fraction |
| TD | tremor-dominant |
| TnT | tunneling nanotubes |
| UPDRS | Unified Parkinson’s Disease Rating Scale |
| VEGF | vascular endothelial growth factor |
| VM | ventral midbrain |
| VPS35 | vacuolar protein sorting-associated protein 35 |
| WHO | World Health Organization |